VARICELLA-ZOSTER VIRUS
Clinical trials for VARICELLA-ZOSTER VIRUS explained in plain language.
Never miss a new study
Get alerted when new VARICELLA-ZOSTER VIRUS trials appear
Sign up with your email to follow new studies for VARICELLA-ZOSTER VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRNA vaccine takes on shingles: could it beat shingrix?
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing a new mRNA vaccine called ABO1108 to prevent shingles in adults aged 40 and above. Around 180 healthy volunteers will receive two shots of either the new vaccine at different doses, a placebo, or the existing Shingrix vaccine. The main goal is to…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:32 UTC
-
New mRNA shingles vaccine shows promise in Mid-Stage trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new mRNA vaccine called ABO1108 to see if it can prevent shingles in adults aged 40 and above. About 300 healthy volunteers will receive two shots, two months apart, and be compared to a placebo group. The goal is to measure the immune response and check for sa…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC